Table 4.
Self-rated health of the whole sample in relation to demographic variables and self-reported diseases
|
Variables |
Mean (N) |
SD |
Mean (N) |
SD |
p
value |
Effect size |
|---|---|---|---|---|---|---|
| Self-reported diseases | Present | Absent | ||||
| Hypertension |
61.7 (2307) |
18.0 |
64.3 (882) |
18.5 |
<0.001 |
0.14 |
| Joint arthrosis |
60.0 (2115) |
17.9 |
67.2 (1072) |
17.8 |
<0.001 |
0.40 |
| Chronic low back pain |
59.1 (1975) |
18.2 |
68.0 (1208) |
16.9 |
<0.001 |
0.49 |
| Chronic ischemic heart disease |
59.4 (963) |
18.8 |
63.7 (2220) |
17.8 |
<0.001 |
0.24 |
| Severe vision reduction |
60.8 (1396) |
18.3 |
63.7 (1786) |
18.0 |
<0.001 |
0.12 |
| Diabetes mellitus |
61.0 (992) |
18.0 |
63.1 (2188) |
18.3 |
0.004 |
0.12 |
| Cardiac arrhythmia |
59.0 (1046) |
18.2 |
64.1 (2139) |
18.0 |
<0.001 |
0.28 |
| Neuropathies |
57.1 (1114) |
18.2 |
65.2 (2075) |
17.6 |
<0.001 |
0.45 |
| Dizziness |
57.1 (1109) |
17.9 |
65.3 (2078) |
17.7 |
<0.001 |
0.45 |
| Lower limb varicosis |
61.1 (1148) |
18.4 |
63.2 (2037) |
18.0 |
0.002 |
0.12 |
| Asthma/COPD1 |
58.0 (696) |
18.5 |
63.7 (2491) |
17.9 |
<0.001 |
0.31 |
| Purine/pyrimidine metabolism disorders/Gout |
57.7 (536) |
18.1 |
63.4 (2643) |
18.1 |
<0.001 |
0.31 |
| Hemorrhoids |
59.9 (727) |
18.4 |
63.2 (2459) |
18.1 |
<0.001 |
0.18 |
| Cerebral ischemia/Chronic stroke |
59.3 (444) |
18.4 |
62.9 (2742) |
18.1 |
<0.001 |
0.20 |
| Cardiac insufficiency |
55.7 (548) |
18.4 |
63.8 (2632) |
17.8 |
<0.001 |
0.45 |
| Atherosclerosis/PAOD2 |
54.6 (347) |
19.9 |
63.4 (2835) |
17.8 |
<0.001 |
0.48 |
| Renal insufficiency |
55.1 (307) |
19.1 |
63.2 (2875) |
17.9 |
<0.001 |
0.45 |
| Intestinal diverticulosis |
60.8 (435) |
17.7 |
62.7 (2751) |
18.3 |
0.046 |
0.10 |
| Rheumatoid arthritis |
55.0 (410) |
18.8 |
63.5 (2768) |
17.8 |
<0.001 |
0.47 |
| Osteoporosis |
57.4 (690) |
18.7 |
63.8 (2496) |
17.8 |
<0.001 |
0.35 |
| Chronic cholecystitis/Gallstones |
59.1 (271) |
18.4 |
62.7 (2917) |
18.2 |
0.002 |
0.20 |
| Anemia |
55.2 (169) |
18.1 |
62.8 (3017) |
18.1 |
<0.001 |
0.42 |
| Migraine |
58.8 (166) |
18.6 |
62.6 (3022) |
18.2 |
0.008 |
0.21 |
| Parkinson’s disease |
49.5 (67) |
18.4 |
62.7 (3121) |
18.1 |
<0.001 |
0.73 |
| Lipid metabolism disorders |
61.8 (1460) |
17.9 |
62.9 (1721) |
18.4 |
0.10 |
0.06 |
| Thyroid dysfunction |
61.7 (991) |
18.2 |
62.7 (2196) |
18.2 |
0.15 |
0.05 |
| Prostate hyperplasia |
63.3 (510) |
17.7 |
63.8 (779) |
18.8 |
0.63 |
0.03 |
| Non-inflammatory gynecological problems |
60.8 (245) |
19.7 |
61.7 (1631) |
17.8 |
0.45 |
0.05 |
| Cardiac valve disorders |
61.4 (314) |
18.4 |
62.5 (2872) |
18.2 |
0.31 |
0.06 |
| Kidney stones |
60.7 (124) |
18.5 |
62.5 (3063) |
18.2 |
0.29 |
0.10 |
| Psoriasis |
61.4 (213) |
19.2 |
62.5 (2976) |
18.1 |
0.39 |
0.06 |
| Malignant tumors |
60.9 (332) |
18.0 |
62.6 (2850) |
18.2 |
0.11 |
0.09 |
|
Sex |
Males |
Females |
|
|
||
| |
63.6 (1298) |
18.4 |
61.6 (1891) |
18.0 |
0.003 |
0.11 |
|
Marital status |
Married |
Non married |
|
|
||
| |
63.3 (1863) |
18.2 |
61.2 (1326) |
18.2 |
0.001 |
0.12 |
|
Household type |
With others |
|
Living alone |
|
|
|
| |
63.0 (2061) |
18.2 |
61.3 (1128) |
18.2 |
0.011 |
0.09 |
|
Education |
High |
Low/Intermediate |
|
|
||
| |
67.1 (347) |
18.7 |
61.8 (2842) |
18.1 |
<0.001 |
0.29 |
|
Smoking behavior |
Smoker |
Non-smoker |
|
|
||
| 61.5 (237) | 18.4 | 62.5 (2948) | 18.2 | 0.42 | 0.05 | |
Note: By t-test differences in SRH between different groups were tested for significance; confidence interval: 99%; only significant results are shown in the table.
Marital status: not married includes: single, divorced, widowed; household type: living with others includes: with partner, family members and in an institution; 1: chronic obstructive pulmonary disease; 2: peripheral arterial occlusive disease.